Fundz
Funding, M&A and exec moves matched to your market, guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

Rhelion Life Sciences acquires Filament Health Corp.

PRIVATEAug 19, 2026about 6 hours ago

Acquiring Company

Rhelion Life Sciences

Acquired Company

Filament Health

TorontoBiotechnologyHealth CareBiotechnologyHealth CareTherapeutics

Description

Rhelion Life Sciences Corp. has successfully acquired Filament Health Corp. This acquisition reinforces Rhelion's commitment to developing naturally derived psychedelic medicines. With this integration, Rhelion enhances its pharmaceutical capabilities and patent portfolio, positioning itself for continued growth in the life sciences sector.

Company Information

Company

Rhelion Life Sciences

Location

Toronto, Ontario, Canada

About

Rhelion Life Sciences Corp. is focused on advancing naturally derived psychedelic medicines through drug development and manufacturing. The company has transformed its business through the acquisition of Filament Health. Rhelion also specializes in clinical research and the regulated supply of psychedelic drug candidates. With 76 issued patents, it is positioned at the forefront of this niche sector.

Don't miss Rhelion Life Sciences's next move

Get an email the moment Rhelion Life Sciences makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Rhelion Life Sciences's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Filament Health?

Filament Health was acquired by Rhelion Life Sciences, based in Toronto. The deal was reported on August 19, 2026. Rhelion Life Sciences Corp. is focused on advancing naturally derived psychedelic medicines through drug development and manufacturing. Rhelion Life Sciences is privately held and operates in Biotechnology.

When did Rhelion Life Sciences acquire Filament Health?

Rhelion Life Sciences's acquisition of Filament Health was reported on August 19, 2026. Rhelion Life Sciences Corp. has successfully acquired Filament Health Corp. This acquisition reinforces Rhelion's commitment to developing naturally derived psychedelic medicines. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Filament Health do?

Filament Health Corp. is dedicated to the development of botanical psychedelic drug candidates. The company offers pharmaceutical-grade products and has experience in regulatory matters with Health Canada and the FDA. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.